Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
Psychotherapy technique can help reduce dementia caregivers' stress

Psychotherapy technique can help reduce dementia caregivers' stress

Novartis files suit against Watson over generic Exelon

Novartis files suit against Watson over generic Exelon

State roundup: Alaska's dental problem; some Minn. health funding blocked

State roundup: Alaska's dental problem; some Minn. health funding blocked

ESPINA software tool allows to study brain structure in greater depth

ESPINA software tool allows to study brain structure in greater depth

PCMD researcher receives Alzheimer's Association grant to study dementia

PCMD researcher receives Alzheimer's Association grant to study dementia

Patients with Parkinson's may have increased risk of leg motor restlessness

Patients with Parkinson's may have increased risk of leg motor restlessness

Idera third quarter net loss increases to $5.5 million

Idera third quarter net loss increases to $5.5 million

Positive results from NeuroDerm's ND0611 Phase I/II study for advanced Parkinson's disease

Positive results from NeuroDerm's ND0611 Phase I/II study for advanced Parkinson's disease

Benefits of hormone replacement therapy in protecting women from Alzheimer's inconclusive

Benefits of hormone replacement therapy in protecting women from Alzheimer's inconclusive

Ligand third quarter total revenues decrease to $5.7 million

Ligand third quarter total revenues decrease to $5.7 million

Higher protein load in critical brain regions linked to severe depression in late life

Higher protein load in critical brain regions linked to severe depression in late life

Stem cell therapy for Parkinson’s

Stem cell therapy for Parkinson’s

Polystyrene surface triples number of human ES and iPS cells in culture

Polystyrene surface triples number of human ES and iPS cells in culture

Low-grade inflammatory processes drive development of osteoarthritis

Low-grade inflammatory processes drive development of osteoarthritis

A person's stroke risk profile may help identify future cognitive problems

A person's stroke risk profile may help identify future cognitive problems

Hirano bodies may play a protective role in progression of Alzheimer's

Hirano bodies may play a protective role in progression of Alzheimer's

Researchers discover key mechanism responsible for degrading ubiquitinated protein aggregates

Researchers discover key mechanism responsible for degrading ubiquitinated protein aggregates

Unprecedented detailed description of MAP kinase complex structure

Unprecedented detailed description of MAP kinase complex structure

Chemical breakthrough could simplify drug development process

Chemical breakthrough could simplify drug development process

Daily intake of Souvenaid improves memory in people with mild AD

Daily intake of Souvenaid improves memory in people with mild AD

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.